B. Braun Melsungen AG:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:B. Braun Melsungen AG - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7118
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:63
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
B. Braun Melsungen AG (B. Braun) develops, manufactures and distributes medical technology and pharmaceutical products, and provides medical services worldwide. The company’s major products include solutions and disposables for infusion, nutrition and pain therapy, infusion pumps and systems, suture materials, hip and knee implants, surgical instruments, dialysis equipment and accessories, stoma and wound care products. B. Braun provides products and systems for the fields of anesthesia, intensive care, cardiology, extracorporeal blood treatment and surgery, besides services for clinics, physician practices, and the home care segment. The company sells products directly in Europe, the Americas, Asia-Pacific, Africa and the Middle East. B. Braun is headquartered in Melsungen, Germany.

B. Braun Melsungen AG – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
B. Braun Melsungen AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
B. Braun Melsungen AG, Medical Equipment Deals By Type, 2012 to YTD 2018 7
B. Braun Melsungen AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
B. Braun Melsungen AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
B. Braun Melsungen AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
B. Braun Melsungen AG, Medical Equipment, Deal Details 12
Asset Purchase 12
B. Braun Medical to Acquire Bloodlines Business from NxStage Medical 12
B. Braun Medical Acquires Stoma Care Assets from Stimatix GI 13
Venture Financing 14
Gordian Surgical Raises USD2.3 Million in Financing Round 14
Partnerships 15
Aesculap Forms Joint Venture with Christoph Miethke 15
Christie Medical Enters into Agreement with B. Braun Medical 16
B. Braun Enters into Parntership with Royal Philip 17
B. Braun Interventional Systems Forms Partnership with NuMED 18
ICU Medical Enters into Distribution Agreement with B. Braun Melsungen 19
Proxy Biomedical Extends Distribution Agreement with B. Braun Surgical 20
Cohera Medical Enters into Distribution Agreement with B. Braun Surgical 21
Kinetic Concepts Enters Into An Agreement With B. Braun Medical For Prontosan 22
B. Braun Medical Enters into Co-Marketing Agreement with RyMed for InVision-Plus 23
B. Braun Medical Forms Joint Venture with CeGaT 24
Yungjin Enters Into Distribution Agreement With B. Braun For Enteral Nutrition Products 25
Maquet Enters Into Co-Marketing Agreement With Aesculap For OR Integration Solutions 26
Misonix Enters Into Distribution Agreement With B. Braun Medical 27
Osseon Therapeutics Enters Into Co-Marketing Agreement With Aesculap 28
Equity Offering 29
Fidmi Medical Raises USD2 Million in Private Placement 29
ApiFix Raises USD2.8 Million in Private Placement of Shares 30
Asset Transactions 31
DaVita HealthCare To Acquire Dialysis Products From B. Braun Medical 31
Acquisition 32
B. Braun Medical Acquires Dismed Pharma and Dismed Criticare 32
B. Braun Avitum Acquires Lauer Membran Wassertechnik 33
B. Braun Medical Acquires Carenalis 34
B. Braun Avitum Acquires 51% Stake in Dialy Ser 35
B. Braun Medical International Acquires 60% Stake In Ventas Paraguayas, Medical Equipment Distributor 36
B. Braun Melsungen Acquires 20% Stake In CeGaT 37
B. Braun Melsungen AG – Key Competitors 38
B. Braun Melsungen AG – Key Employees 39
B. Braun Melsungen AG – Locations And Subsidiaries 40
Head Office 40
Other Locations & Subsidiaries 40
Joint Venture 44
Recent Developments 45
Strategy And Business Planning 45
Dec 12, 2017: B. Braun establishes a subsidiary in Zambia 45
Jul 28, 2017: Indonesian Minister of Health Launches New German Pharmaceutical Factory in Karawang 46
Financial Announcements 47
Mar 23, 2018: 2017 fiscal year: B. Braun increases sales and earnings, with investments of one billion euros 47
Mar 31, 2017: B. Braun continues its sales and earnings growth 49
Corporate Communications 51
Jul 12, 2018: Personnel Changes in Supervisory and Management Board of Aesculap 51
Jul 31, 2017: Dr. Joachim Schulz joins the Management Board of B. Braun Melsungen 52
Apr 12, 2017: Change in the B. Braun Management Board and the Aesculap Management Board 53
Feb 22, 2017: Change in the B. Braun Management Board 54
Product News 55
Sep 12, 2018: B. Braun focused on peripheral intravenous access at AVA 55
Sep 06, 2018: Innovative solutions and exiting entrepreneurs: B. Braun Accelerator Demo Day 56
May 03, 2017: B. Braun Focused on Peripheral Vascular Access & Hazardous Drug Safety at INS 57
Other Significant Developments 58
Sep 04, 2018: B. Braun inaugurates Europe’s most modern production site in Saxony 58
Jun 21, 2018: GS1 Ireland Launches Groundbreaking Global Operating Room Data Collection Study at Arizona Hospital 59
Feb 13, 2018: Four start-ups chosen for the B. Braun Accelerator Program 60
Jun 08, 2017: B. Braun is participating in the third edition of the High-Tech Founders Fund 61
Feb 15, 2017: B. Braun Medical to Present Comprehensive Parenteral Nutrition Program at ASPEN’s Clinical Nutrition Week 62
Appendix 63
Methodology 63
About GlobalData 63
Contact Us 63
Disclaimer 63

List of Tables
B. Braun Melsungen AG, Medical Equipment, Key Facts, 2017 2
B. Braun Melsungen AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
B. Braun Melsungen AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
B. Braun Melsungen AG, Medical Equipment Deals By Type, 2012 to YTD 2018 7
B. Braun Melsungen AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
B. Braun Melsungen AG, Deals By Market, 2012 to YTD 2018 9
B. Braun Melsungen AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
B. Braun Medical to Acquire Bloodlines Business from NxStage Medical 12
B. Braun Medical Acquires Stoma Care Assets from Stimatix GI 13
Gordian Surgical Raises USD2.3 Million in Financing Round 14
Aesculap Forms Joint Venture with Christoph Miethke 15
Christie Medical Enters into Agreement with B. Braun Medical 16
B. Braun Enters into Parntership with Royal Philip 17
B. Braun Interventional Systems Forms Partnership with NuMED 18
ICU Medical Enters into Distribution Agreement with B. Braun Melsungen 19
Proxy Biomedical Extends Distribution Agreement with B. Braun Surgical 20
Cohera Medical Enters into Distribution Agreement with B. Braun Surgical 21
Kinetic Concepts Enters Into An Agreement With B. Braun Medical For Prontosan 22
B. Braun Medical Enters into Co-Marketing Agreement with RyMed for InVision-Plus 23
B. Braun Medical Forms Joint Venture with CeGaT 24
Yungjin Enters Into Distribution Agreement With B. Braun For Enteral Nutrition Products 25
Maquet Enters Into Co-Marketing Agreement With Aesculap For OR Integration Solutions 26
Misonix Enters Into Distribution Agreement With B. Braun Medical 27
Osseon Therapeutics Enters Into Co-Marketing Agreement With Aesculap 28
Fidmi Medical Raises USD2 Million in Private Placement 29
ApiFix Raises USD2.8 Million in Private Placement of Shares 30
DaVita HealthCare To Acquire Dialysis Products From B. Braun Medical 31
B. Braun Medical Acquires Dismed Pharma and Dismed Criticare 32
B. Braun Avitum Acquires Lauer Membran Wassertechnik 33
B. Braun Medical Acquires Carenalis 34
B. Braun Avitum Acquires 51% Stake in Dialy Ser 35
B. Braun Medical International Acquires 60% Stake In Ventas Paraguayas, Medical Equipment Distributor 36
B. Braun Melsungen Acquires 20% Stake In CeGaT 37
B. Braun Melsungen AG, Key Competitors 38
B. Braun Melsungen AG, Key Employees 39
B. Braun Melsungen AG, Subsidiaries 40
B. Braun Melsungen AG, Joint Venture 44

List of Figures
B. Braun Melsungen AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
B. Braun Melsungen AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
B. Braun Melsungen AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
B. Braun Melsungen AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
B. Braun Melsungen AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
B. Braun Melsungen AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
B. Braun Melsungen AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
B. Braun Melsungen AG, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[B. Braun Melsungen AG:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cadence Design Systems, Inc.:企業の戦略・SWOT・財務情報
    Cadence Design Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Cadence Design Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Venture Corporation Limited:企業の戦略・SWOT・財務分析
    Venture Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Venture Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Helvetia Group:企業の戦略・SWOT・財務情報
    Helvetia Group - Strategy, SWOT and Corporate Finance Report Summary Helvetia Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Ansell Limited:企業の戦略・SWOT・財務分析
    Ansell Limited - Strategy, SWOT and Corporate Finance Report Summary Ansell Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • OriGene Technologies Inc-医療機器分野:企業M&A・提携分析
    Summary OriGene Technologies Inc (OriGene) is a research tool company that develops cDNA. The company creates commercial collection of full-length human cDNAs in expression vector. It develops, manufactures and sells genome research and diagnostic products. OriGene’s products include qPCR reagents, …
  • ALS Limited (ALQ)-石油・ガス分野:企業M&A・提携分析
    Summary ALS Limited (ALS), formerly, Campbell Brothers Limited is a diversified testing service provider. The company provides testing services in the areas of minerals, life sciences, energy and industrial. It provides chemical and laboratory services, technical testing and inspection services supp …
  • Aabar Investments:企業の戦略的SWOT分析
    Aabar Investments - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Sabah Electricity Sdn Bhd:企業の戦略的SWOT分析
    Sabah Electricity Sdn Bhd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Harbin Electric International Co Ltd:企業の戦略的SWOT分析
    Harbin Electric International Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Cross Country Healthcare Inc (CCRN):企業の財務・戦略的SWOT分析
    Cross Country Healthcare Inc (CCRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Iconic Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Iconic Therapeutics Inc (Iconic Therapeutics) is a biopharmaceutical company that provides translation of scientific insight into breakthrough medicines. The company offers development of tissue factor in inflammation, angiogenesis, and metastasis that led to develop new approach to retinal …
  • Ambry Genetics Corp-製薬・医療分野:企業M&A・提携分析
    Summary Ambry Genetics Corp (Ambry Genetics) is a biotechnology company that offers genetic testing services. The company offers clinical diagnostics services, which include tests, forms, billing, managed care, order kits, reporting, licenses, family studies program, variant classification and secur …
  • Ann Inc:企業の戦略的SWOT分析
    Ann Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Bancolombia SA (BCOLOMBIA):企業の財務・戦略的SWOT分析
    Bancolombia SA (BCOLOMBIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Muang Thai Life Assurance Public Company Limited:企業の戦略・SWOT・財務情報
    Muang Thai Life Assurance Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Muang Thai Life Assurance Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, …
  • Columbia Banking System Inc:企業の戦略・SWOT・財務情報
    Columbia Banking System Inc - Strategy, SWOT and Corporate Finance Report Summary Columbia Banking System Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Adhera Therapeutics (MRNA):製薬・医療:M&Aディール及び事業提携情報
    Summary Adhera Therapeutics (Adhera) is a nucleic acid-based drug discovery and development company that focuses on rare diseases. It focuses on treating the intersection of arthritis, hypertension, pain, and cancer using combination therapies of already approved drugs. The company is developing and …
  • Choppies Enterprises Ltd:企業の戦略的SWOT分析
    Choppies Enterprises Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Cordis Corp-医療機器分野:企業M&A・提携分析
    Summary Cordis Corporation (Cordis), a subsidiary of a Cardinal Health Inc., develops and manufactures interventional vascular products in the area of cardiology as well as for use in endovascular surgery. The company’s cardiology portfolio comprises sheaths, diagnostic guidewires, diagnostic cathet …
  • Aabar Investments:企業の戦略的SWOT分析
    Aabar Investments - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆